Princeton Global Asset Management LLC Bristol Myers Squibb CO Transaction History

Princeton Global Asset Management LLC

$507 Million
Q4 2024

A detailed history of Princeton Global Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Princeton Global Asset Management LLC holds 2,186 shares of BMY stock, worth $133,542. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,186

Previous 2,532 13.67%

Holding current value

$133,542

Previous $131,000 6.11%

% of portfolio

0.02%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	SELL	$51.92 - $59.94 $17,964 - $20,739	-346 Reduced 13.67%	2,186 $123,000
Q3 2024 Oct 29, 2024	SELL	$39.66 - $51.75 $14,912 - $19,458	-376 Reduced 12.93%	2,532 $131,000
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $48,984 - $64,488	-1,217 Reduced 29.5%	2,908 $120,000
Q4 2023 Jan 22, 2024	SELL	$48.48 - $57.85 $1.68 Million - $2 Million	-34,599 Reduced 89.35%	4,125 $211,000
Q3 2023 Oct 27, 2023	SELL	$57.89 - $64.73 $64,663 - $72,303	-1,117 Reduced 2.8%	38,724 $2.25 Million
Q2 2023 Aug 04, 2023	SELL	$63.71 - $70.74 $436,413 - $484,568	-6,850 Reduced 14.67%	39,841 $2.55 Million
Q1 2023 Apr 20, 2023	BUY	$65.71 - $74.53 $270,659 - $306,989	4,119 Added 9.68%	46,691 $3.24 Million
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $167,022 - $197,778	2,439 Added 6.08%	42,572 $3.06 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $23 - $13,754	-179 Reduced 0.44%	40,133 $2.85 Million
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $50,543 - $55,666	696 Added 1.76%	40,312 $3.1 Million
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $50,044 - $60,008	814 Added 2.1%	39,616 $2.89 Million
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $90,044 - $104,971	-1,679 Reduced 4.15%	38,802 $2.42 Million
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $2.25 Million - $2.64 Million	38,086 Added 1590.23%	40,481 $2.4 Million
Q3 2021 Nov 03, 2021	SELL	$59.17 - $69.31 $2.22 Million - $2.6 Million	-37,567 Reduced 94.01%	2,395 $2.4 Million
Q2 2021 Aug 04, 2021	SELL	$61.91 - $67.42 $91,688 - $99,849	-1,481 Reduced 3.57%	39,962 $2.67 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $56,254 - $63,269	948 Added 2.34%	41,443 $2.62 Million
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $8,776 - $9,945	-152 Reduced 0.37%	40,495 $2.51 Million
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $686,231 - $760,434	-11,949 Reduced 22.72%	40,647 $2.45 Million
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $472,822 - $552,776	8,625 Added 19.62%	52,596 $3.09 Million
Q1 2020 Apr 28, 2020	BUY	$46.4 - $67.43 $1.49 Million - $2.17 Million	32,196 Added 273.43%	43,971 $2.45 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $123,025 - $160,475	2,500 Added 26.95%	11,775 $756,000
Q3 2019 Dec 03, 2019	BUY	$42.77 - $50.71 $54,531 - $64,655	1,275 Added 15.94%	9,275 $470,000
Q1 2019 May 23, 2019	BUY	$45.12 - $53.8 $30,681 - $36,584	680 Added 9.29%	8,000 $381,000
Q4 2018 Feb 26, 2019	BUY	$48.76 - $63.23 $356,923 - $462,843	7,320 New	7,320 $380,000

Others Institutions Holding BMY

# of Institutions

2,761

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $130B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Global Asset Management LLC with notifications on news.

Account

Princeton Global Asset Management LLC Bristol Myers Squibb CO Transaction History